What is PMCB (PMCB) stock price today?

PMCB (PMCB) is currently trading at $0.59, up 0% today.

What is PMCB P/E ratio?

PMCB's P/E ratio is 0.24. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is PMCB return on equity (ROE)?

PMCB's return on equity (ROE) is 59.62%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is PMCB's market cap?

PMCB has a market capitalization of $4.01M.

NASDAQ · Biotechnology

PMCB (PMCB) Stock

$0.59 +0.00% NASDAQ: PMCB Healthcare

Valuation

Metric	Value
Price	$0.59
Market Cap	$4.01M
P/E Ratio	0.24
P/B Ratio	0.10
P/S Ratio	0.00
EPS (TTM)	$3.19
52-Week High	$1.51
52-Week Low	$0.59
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	59.62%
ROA	56.36%
ROCE	-7.69%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	7.33

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-4.0M	$-4.0M	$-6.0M	$-7.0M	$-4.0M
Net Profit	$-4.0M	$-4.0M	$-4.0M	$0	$31.0M
EPS	$-2.46	$-0.79	$-0.83	$-1.80	$3.19
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$7.0M	$91.0M	$73.0M	$60.0M	$55.0M
Total Liabilities	$1.0M	$1.0M	$1.0M	$20.0M	$3.0M
Cash	$2.0M	$85.0M	$68.0M	$50.0M	$15.0M
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-3.0M	$-4.0M	$-4.0M	$-2.0M	$-3.0M
Investing Cash Flow	$0	$0	$0	$-5.0M	$-7.0M
Financing Cash Flow	$0	$0	$-14.0M	$-44.0M	$-24.0M
Net Cash Flow	$1.0M	$83.0M	$-17.0M	$-18.0M	$-35.0M
Free Cash Flow	$-3.0M	$-4.0M	$-4.0M	$-2.0M	$-3.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-91.96%
Quick Ratio	12.33
Interest Coverage	—
Return 1Y	-36.20%
Return 3Y	-75.07%
Return 5Y	-94.62%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BCLIBrainstorm Cell Therapeutics Inc.	$0.98	+6.52%	-1.04	$10.81M	0.00%
CYCN	$3.57	+0.28%	-2.99	$16.71M	0.00%
IBO	$0.43	-2.27%	-1.61	$5.38M	0.00%
KTTA	$0.45	-2.17%	-0.25	$3.35M	0.00%
NBYNovaBay Pharmaceuticals, Inc.	$1.47	-24.62%	0.09	$39.14M	2.72%

About PMCB

PMCB is led by CEO Joshua N. Silverman, employs 2 people, headquartered in US, publicly traded since 2013.

PMCB stock trades at $0.59 with a market capitalization of $4.01M. The stock is valued at a price-to-earnings (P/E) ratio of 0.24, price-to-book of 0.10, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.59 and $1.51, and currently trades 60.9% below its 52-week high.

On profitability, PMCB generates a return on equity (ROE) of 59.62% — well above the market average, a sign of a high-quality business, return on capital employed of -7.69%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides